期刊文献+

高血压合并冠心病病人脂蛋白相关磷脂酶A_2、类胰蛋白酶水平变化的相关研究 被引量:8

Correlation of Lipoprotein Associated Phospholipase A_2 and Serum Tryptase in Patients with Hypertension Complicated with Coronary Heart Disease
下载PDF
导出
摘要 目的观察脂蛋白相关磷脂酶A_2、(LP-PLA_2)、血清类胰蛋白酶(TPS)在高血压合并冠心病病人的水平变化,探讨其与颈动脉内中膜厚度(IMT)、冠脉病变程度的相关性及临床意义。方法选择临床确诊的伴有高血压的冠心病病人65例,不伴有高血压的冠心病病人55例,单纯高血压病30名,健康体检者30名(对照组)。采用酶联免疫法检测所有病人LP-PLA_2、TPS水平,比较各组间差异,并分析其与颈动脉内中膜厚度、冠脉病变程度的相关性。结果 LP-PLA_2、TPS水平在单纯高血压组、冠心病组水平均高于对照组,且伴有高血压的冠心病组LP-PLA_2、TPS水平高于不伴高血压的冠心病组和单纯高血压病组。LP-PLA_2、TPS水平与IMT存在正相关(偏回归系数分别为5.681、0.323,P<0.05),两者与冠状动脉Gensini评分呈明显正相关(偏回归系数分别为8.191、0.318,P<0.05)。结论 LP-PLA_2、TPS作为炎性因子参与高血压的发生发展过程,随着高血压炎症反应的不断增强,其水平随之升高,且同相关靶器官损害的特异标记有相关性,表明二者可以作为高血压风险程度的预警因子。 Objective To compare the levels of lipoprotein associated phospholipase A2(LP- PLA2) and serum tryptase (TPS) in patients of essential hypertension (EH) complicated with coronary heart disease (CHD) , and explore the clinical correlation between them and intimamedia thickness and coronary artery lesion degree.Methods Sixty- five patients with EH complicated with CHD, 55 patients with CHD, 30 patients with hypertension were participated in the study.Thirty healthy individuals were as controls.The levels of LP PLA2 and TPS were detected by enzyme - linked immunoassay.The correlation of LP - PLA2 and TPS levels with the carotid artery in the film thickness (IMT) and coronary artery lesion degree were analyzed.Results The levels of LP - PLA2 and TPS at the pure hypertension, coronary heart disease group were higher than the control group, and accompanied by hypertension coronary heart disease group LP PLA2, TPS level higher than that of without hypertension coronary heart disease (CHD) and pure hypertension group.LP PLA2, TPS levels were positively correlated with IMT (partial regression coefficient were 5.681 and 0.323, P 〈0.05), with both coronary artery Gensini score was significantly positive correlation (partial regression coefficient were 8.191 and 0.318, P 〈0.05). Conclusion As inflammatory factors, LP- PLA2 and TPS involved in pathological progress of hypertension and inflammation.With the levels increasing, and correlated with specific markers with related target organs damage, shows that the degree of risk warning factor can be used as high blood pressure.
机构地区 山西省人民医院
出处 《中西医结合心脑血管病杂志》 2016年第13期1445-1448,共4页 Chinese Journal of Integrative Medicine on Cardio-Cerebrovascular Disease
基金 山西省科技攻关项目(No.20120313018-8)
关键词 高血压 冠心病 脂蛋白相关磷脂酶A_2 血清类胰蛋白酶 lipoprotein associated phospholipase A2 tryptase hypertension coronary heart disease
  • 相关文献

参考文献19

  • 1Androulakis E,Tousoulis D, Papageorgiou N, et al .Inflammation in hypertension,curre therapeutic approaches[J].Current Phar- maceutical design, 2011,17(37) : 4121 - 4131.
  • 2Libby P, Ridker PM, Maseri A.Inflammation and atherosclerosis [J].Circulation, 2002,105(9) : 1135 - 1143.
  • 3张鹭,张浩.磷脂酶A2及其功能概述[J].齐齐哈尔医学院学报,2004,25(2):178-180. 被引量:15
  • 4Vadas P, Pruzanski W.lnduction of group 1] phospholipase A2 eression and pathogenesis of the sepsis syndrome[J].Circulato- ry Shock, 1993,39:160 - 172.
  • 5Chait A, Han CY, Oram JF; et aI.The immune system and atherogenesis, lipoprotein - associated inflammatory proteins: markers or mediators of cardiovascular disease[J].Journal of Lipid Research, 2005,46:389 - 403.
  • 6赵颖,杨军,董天崴,李莉,李海涛,李贵华,金钟一,皮林.脂蛋白相关磷脂酶A2与原发性高血压的相关性[J].心血管康复医学杂志,2012,21(2):133-136. 被引量:6
  • 7MacPhee CH, Moores KE, Boyd HF. Lipoprotein - associated phospholipase A2, platelet - activating factor acetylhydrolase, generates two bioactive products during the oxidation of low- density lipoprotein: use of a novel inhibitor[J].The Biochemical Journal, 1999,338(2) : 479 - 487.
  • 8Tsimikas S, Tsironis AD.New insights into the role of lipoprotein - associated phospholipase A2 in the atherosclerosis and cardio- vascular disease.[J].Arterioscler Thromb Vasc Biol, 2007, 27, 2094 - 2099.
  • 9亢爱春,霍勇,齐丽彤.溶血磷脂酰胆碱在动脉粥样硬化中的作用[J].中国动脉硬化杂志,2006,14(12):1083-1086. 被引量:26
  • 10Lavi S,McConnell JP, Rihal CS, et al .Local production of lipo- protein - associated phospholipaee A2 and lysophosphatidylcho- line in the circulation, association with early coronary atheroscle rosis and endothelial dysfunction in humans[J].Circulation, 2007,115(21) :2715 - 2721.

二级参考文献53

  • 1梁英,刘同涛,田庆印.氨氯地平对溶血磷脂酰胆碱致培养人脐静脉内皮细胞损伤的保护作用[J].齐鲁医学杂志,2004,19(5):408-409. 被引量:2
  • 2董建勋,路广林,李建,牛福玲,李菲,陈淑长,黄启福.通脉宁拮抗AngⅡ LPC诱导血管平滑肌细胞PDGF-BB蛋白表达的研究[J].中医药学刊,2005,23(12):2161-2162. 被引量:2
  • 3孙国举,谢秀梅,邢莹,鄢文海,杨天崙,余国龙.非诺贝特对LPC诱导脐静脉内皮细胞增殖、凋亡及eNOS基因表达的影响[J].中南大学学报(医学版),2006,31(3):373-378. 被引量:4
  • 4刘松.-[J].国外医学:呼吸系统分册,1997,17(3):128-130.
  • 5中国高血压防治指南修订委员会.中国高血压防治指南.高血压杂志,2005,13(1):2-41.
  • 6Keiji Tabuchi,Zenya Ito,Shigeki Tsuji,Tetsuro Wada,Kazuhiko Takahashi,Akira Hara,Tetsuro Wada,KazuhikoTakahashi,Akira Hara,Jun Kusakari. The contribution of phospholipase A2 to the cochlear dysfunction induced by transient ischemia[J]. Hearing Research,20
  • 7Julian N·Kanfer,giuseppe Sorrentino,Daniel S·Sitar. Phospholipases as mediators of amyloid beta peptide neurotoxicity:an early event contributing to neurodegeneration characteristic of Alzheimer's disease[J].Neuroscience Letters,1988,257:93-96
  • 8Stephen P·Young. Inhibition of endosome fusion in primary hepatocytes prevents asialoglycoprotein degradation but not uptake of transferrin iron demonstrating that intracellular iron release occurs from early endosomes[J].FEBS Letters,2000,466:135-138
  • 9Dennis E.A.(1997)Trends Biochem.Sci.22:1-2
  • 10Colin H.Macphee. Lipoprotein-associated phospholipase A2: a potential new risk factor for coronary artery disease and a therapeutic target, Current Opinion in pharmacology,2001,1:121-125

共引文献44

同被引文献77

二级引证文献86

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部